P53 IS REQUIRED FOR RADIATION-INDUCED APOPTOSIS IN MOUSE THYMOCYTES

被引:2862
作者
LOWE, SW
SCHMITT, EM
SMITH, SW
OSBORNE, BA
JACKS, T
机构
[1] MIT,CTR CANC RES,DEPT BIOL,77 MASSACHUSETTS AVE,CAMBRIDGE,MA 02139
[2] UNIV MASSACHUSETTS,DEPT VET & ANIM SCI,AMHERST,MA 01003
[3] UNIV MASSACHUSETTS,PAIGE LAB 309,PROGRAM MOLEC & CELLULAR BIOL,AMHERST,MA 01003
关键词
D O I
10.1038/362847a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
THE p53 tumour suppressor gene is the most widely mutated gene in human tumorigenesis1,2. p53 encodes a transcriptional activator3-7 whose targets may include genes that regulate genomic stability8,9, the cellular response to DNA damage10,11, and cell-cycle progression12-13. Introduction of wild-type p53 into cell lines that have lost endogenous p53 function can cause growth arrest14-16 or induce a process of cell death known as apoptosis17,18. During normal development, self-reactive thymocytes undergo negative selection by apoptosis19, which can also be induced in immature thymocytes by other stimuli, including exposure to glucocorticoids15 and ionizing radiation16. Although normal negative selection involves signalling through the T-cell receptor14, the induction of apoptosis by other stimuli is poorly understood. We have investigated the requirement for p53 during apoptosis in mouse thymocytes. We report here that immature thymocytes lacking p53 die normally when exposed to compounds that may mimic T-cell receptor engagement and to glucocorticoids but are resistant to the lethal effects of ionizing radiation. These results demonstrate that p53 is required for radiation-induced cell death in the thymus but is not necessary for all forms of apoptosis.
引用
收藏
页码:847 / 849
页数:3
相关论文
共 15 条
[1]   P53 FUNCTIONS AS A CELL-CYCLE CONTROL PROTEIN IN OSTEOSARCOMAS [J].
DILLER, L ;
KASSEL, J ;
NELSON, CE ;
GRYKA, MA ;
LITWAK, G ;
GEBHARDT, M ;
BRESSAC, B ;
OZTURK, M ;
BAKER, SJ ;
VOGELSTEIN, B ;
FRIEND, SH .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (11) :5772-5781
[2]   WILD-TYPE P53 ACTIVATES TRANSCRIPTION INVITRO [J].
FARMER, G ;
BARGONETTI, J ;
ZHU, H ;
FRIEDMAN, P ;
PRYWES, R ;
PRIVES, C .
NATURE, 1992, 358 (6381) :83-86
[3]   PRESENCE OF A POTENT TRANSCRIPTION ACTIVATING SEQUENCE IN THE P53 PROTEIN [J].
FIELDS, S ;
JANG, SK .
SCIENCE, 1990, 249 (4972) :1046-1049
[4]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[5]   A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY UTILIZING P53 AND GADD45 IS DEFECTIVE IN ATAXIA-TELANGIECTASIA [J].
KASTAN, MB ;
ZHAN, QM ;
ELDEIRY, WS ;
CARRIER, F ;
JACKS, T ;
WALSH, WV ;
PLUNKETT, BS ;
VOGELSTEIN, B ;
FORNACE, AJ .
CELL, 1992, 71 (04) :587-597
[6]  
KASTAN MB, 1991, CANCER RES, V51, P6304
[7]   ONCOGENIC FORMS OF P53 INHIBIT P53-REGULATED GENE-EXPRESSION [J].
KERN, SE ;
PIETENPOL, JA ;
THIAGALINGAM, S ;
SEYMOUR, A ;
KINZLER, KW ;
VOGELSTEIN, B .
SCIENCE, 1992, 256 (5058) :827-830
[8]   THE P53 TUMOR SUPPRESSOR GENE [J].
LEVINE, AJ ;
MOMAND, J ;
FINLAY, CA .
NATURE, 1991, 351 (6326) :453-456
[9]   ALTERED CELL-CYCLE ARREST AND GENE AMPLIFICATION POTENTIAL ACCOMPANY LOSS OF WILD-TYPE P53 [J].
LIVINGSTONE, LR ;
WHITE, A ;
SPROUSE, J ;
LIVANOS, E ;
JACKS, T ;
TISTY, TD .
CELL, 1992, 70 (06) :923-935
[10]   CELLULAR-LOCALIZATION AND CELL-CYCLE REGULATION BY A TEMPERATURE-SENSITIVE P53-PROTEIN [J].
MARTINEZ, J ;
GEORGOFF, I ;
MARTINEZ, J ;
LEVINE, AJ .
GENES & DEVELOPMENT, 1991, 5 (02) :151-159